Case
Study
Integration, Post-merger Transitions: A Major International Pharmaceutical Organization.The ClientIn 1999, two large pharmaceutical companies merged to form an international biosciences company. This company researches, develops, manufactures, and markets ethical pharmaceuticals, agricultural and specialty chemicals products, and supplies for health care services. They currently employ more than 50,000 people around the world and spend more than $8 million a day on research and development. The ChallengeAs a result of its merger, the company inherited
multiple operating models that were supported by incompatible processes
and legacy systems. During its post-merger consolidation, the company
lost administrative staffing, experienced a malfunction of its contract
management system, and had accounting and financial problems. The SolutionFirst, we designed reporting enhancements using the
existing technologies to allow the company to develop and report
consolidated budget projections across multiple dimensions (product,
project, cost center, and account). Once the time-sensitive reporting
needs were addressed, we led the company through requirement definition
system selection and implementation of a new management reporting and
budgeting system using the Hyperion suite of products. Aspects of this initiative included:
After analyzing information gathered through these
methods, we developed a viable ERP business case and global
implementation strategy. The BenefitsAs a result of Wability’s efforts, this company has
taken an important step toward creating the infrastructure needed to
provide critical financial information to support the needs of the
business. The organization’s finance function now has a management
reporting and budgeting tool capable of providing multiple users the
data and functionality necessary to help them build business plans, and
to monitor and manage costs across the multiple dimensions. The tools
also provide users with simplified reporting and easy access to
information. |